FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to urology, namely to physiotherapy within a rehabilitation system of andrological patients with benign prostatic hyperplasia. A rectal suppository of the preparation VITA-PROST FORTE 100 mg is introduced in rectum. Thereafter, a cylinder inductor 12 cm in diametre of the AVIMP apparatus is applied to a perineum region, above the underclothes in a prone patient with his knees bent and feet rested on a couch. The inductor is rigidly fixed to perform a magnetic therapy procedure characterized by the following parameters: 1st to 5th procedure - magnetic field impulse 45 seconds, frequency 80 Hz; 6th to 10th procedure - magnetic field impulse 45 seconds, frequency 100 Hz, magnetic induction for all procedures 50 mT, procedure duration 10 minutes daily, therapeutic course - 10 procedures.
EFFECT: invention allows to eliminate congestions, to normalise prostate and ejaculate characteristics, to relief pain and discomfort, to avoid dysuric effects, to improve copulative function.
5 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
TREATMENT METHOD OF BENIGN HYPERPLASIA OF PROSTATE GLAND | 2008 |
|
RU2368408C1 |
METHOD OF RESORT THERAPY OF BENIGN PROSTATIC HYPERPLASIA COMPLICATED BY CHRONIC PROSTATITIS WITH DOMINANT SYMPTOM OF NOCTURIA | 2013 |
|
RU2532353C1 |
METHOD FOR TREATING THE CASES OF CHRONIC PROSTATITIS COMBINED WITH BENIGN PROSTATE HYPERPLASIA | 2004 |
|
RU2269369C1 |
METHOD FOR INTERMITTENT THERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2013 |
|
RU2531944C1 |
MEANS FOR CORRECTING UROLOGIC ANDROLOGICAL PATHOLOGIES | 2004 |
|
RU2295336C2 |
METHOD FOR DETERMINATION OF TREATMENT STRATEGY FOR LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA AGAINST THE BACKGROUND OF TESTOSTERONE DEFICIENCY | 2022 |
|
RU2795840C1 |
METHOD OF TREATING BENIGN HYPERPLASIA OF PROSTATE GLAND | 2012 |
|
RU2489093C1 |
METHOD OF TREATING CHRONIC ABACTERIAL PROSTATITIS | 2012 |
|
RU2478408C1 |
AGENT FOR PREVENTING AND TREATING PROSTATITIS AND PROSTATE ADENOMA | 2013 |
|
RU2538615C1 |
MEDICATION FOR TREATING GENITOURINARY SYSTEM DISEASES AND METHOD OF TREATING GENITOURINARY SYSTEM DISEASES | 2011 |
|
RU2565400C2 |
Authors
Dates
2011-01-10—Published
2009-09-28—Filed